Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/30/2008CA2690772A1 Novel peptide amphiphiles having improved solubility and methods of using same
10/30/2008CA2684760A1 Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
10/30/2008CA2684562A1 New use for cannabinoid-containing plant extracts
10/30/2008CA2684003A1 Novel compounds as cannabinoid receptor ligands
10/30/2008CA2683786A1 Titration of tapentadol
10/30/2008CA2683779A1 Tapentadol for treating pain due to osteoarthritis
10/30/2008CA2683520A1 Vaccination regimen for b-cell vaccines
10/30/2008CA2683111A1 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008CA2683053A1 Oligonucleotide compositions for the treatment of alzheimer's disease
10/30/2008CA2682994A1 Heterocyclic compounds with affinity to muscarinic receptors
10/30/2008CA2682671A1 Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
10/30/2008CA2682668A1 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008CA2682539A1 Compounds comprising a cyclobutoxy group
10/30/2008CA2682506A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008CA2680769A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1985311A1 Agent for targeting drug to cerebral neuron
10/29/2008EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds
10/29/2008EP1985307A2 Method and preparation for preventing and/or treating depression
10/29/2008EP1985299A1 Therapeutic agent for traumatic neuropathy and/or movement disorder
10/29/2008EP1985292A1 Titration of tapentadol
10/29/2008EP1984396A2 Inhibitors specific of presenilin-1 and their uses
10/29/2008EP1984374A1 Use of spiro ý imidazolidine-4, 3'-indole¨2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1
10/29/2008EP1984365A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/29/2008EP1984362A1 Process for preparing intermediates to 5-ht4 receptor agonist compounds
10/29/2008EP1984351A1 Compounds having 5-ht6 receptor affinity
10/29/2008EP1984344A2 Multicyclic amino acid derivatives and methods of their use
10/29/2008EP1984339A1 Pyridine derivatives as sodium channel modulators
10/29/2008EP1983991A2 Methods of treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers
10/29/2008EP1983984A2 Tuberous sclerosis treatment
10/29/2008EP1983981A1 Indazole derivatives for treatment of alzheimer's disease
10/29/2008EP1983979A1 Identification of compounds suitable for treating ad
10/29/2008EP1983976A2 Composition comprising a polyunsaturated fatty acid for improving membrane composition
10/29/2008EP1983974A1 Use of kcnq-openers for treating or reducing the symptoms of schizophrenia
10/29/2008EP1751106B1 Piperazine derivatives of alkyl oxindoles
10/29/2008EP1751105B1 Piperazine derivatives of alkyl oxindoles
10/29/2008EP1727809B8 Substituted morpholine and thiomorpholine derivatives
10/29/2008EP1641758B1 Diphenylpyridine derivatives, preparation and therapeutic application thereof
10/29/2008EP1606269B1 Biaryl substituted triazoles as sodium channel blockers
10/29/2008EP1556055B1 Cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure and their use in therapy
10/29/2008EP1487285B9 Alertness bar
10/29/2008EP1441764B1 Antigen arrays comprising rankl for treatment of bone disease
10/29/2008EP1419138B1 N- (1-dimethylaminocycloalkyl)methyl benzamide derivatives
10/29/2008EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns
10/29/2008EP1402005B1 A method of purification of cells
10/29/2008EP1144592B1 Substrate for cell growth
10/29/2008CN101296929A Tricyclic compounds useful as oxytocin receptor agonists
10/29/2008CN101296926A Heterocyclic aspartyl protease inhibitors
10/29/2008CN101296924A Pyrazole-isoquinoline urea derivatives as P38 kinase inhibitors
10/29/2008CN101296703A Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same
10/29/2008CN101296699A Pyrazolo[1,5-a]pyrimidine compounds
10/29/2008CN101293879A Method for preparing quetiapin
10/29/2008CN101293831A Uses of 3-hydroxy fatty acid and its derivative in preparing calcium ion duct modifying agent
10/29/2008CN101293084A Shock-resistant spasm-relieving traditional Chinese medicine preparation and preparing technique
10/29/2008CN101293079A Traditional Chinese medicine for relieving or neutralizing the effect of alcohol
10/29/2008CN101293055A Scutellaria health tea and its processing method
10/29/2008CN101293054A Chinese Medicinal composition for treating kidney Qi deficiency
10/29/2008CN101293051A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293050A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293049A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293048A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293047A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293046A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293045A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293044A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293039A Compound essential oil for refreshing oneself, and eliminating fatigue
10/29/2008CN101293027A Pharmaceutical combination for preventing birth defect and improving anamnesis
10/29/2008CN101293025A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293024A Pharmaceutical combination for preventing birth defect and improving anamnesis
10/29/2008CN101293023A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293022A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293021A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293020A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293019A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293018A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293017A Pharmaceutical composition for preventing birth defection and improving memory
10/29/2008CN101293016A Application of cistanche salsa extract in preparing medicament for treating parkinsonism
10/29/2008CN101293007A Pharmaceutical composition for bearing and rearing better children, preventing birth defect and improving anamnesis
10/29/2008CN101293006A Pharmaceutical composition for bearing and rearing better children, preventing birth defect and improving anamnesis
10/29/2008CN101292994A Method for relieving or neutralizing the effect of alcohol, and products thereof
10/29/2008CN101292990A Use of luteolin-7-O-beta-D glucoside in preparing medicaments for treating dementia diseases
10/29/2008CN101292989A Use of luteolin-7-O-beta-D glucose 1-2 glucoside in preparing medicaments for treating dementia diseases
10/29/2008CN101292988A Use of apigenin -7-O-beta-D glycosides glucuronic acid in preparing medicaments for treating dementia diseases
10/29/2008CN101292972A Use of 3,4-dihydroxy coffee acyl group tartaric acid in preparing medicaments for treating dementia diseases
10/29/2008CN101292971A Use of chicoric acid in preparing medicaments for treating dementia diseases
10/29/2008CN101292960A Sustained-release microsphere containing risperidone and preparation method thereof
10/29/2008CN101292764A Sobering food
10/29/2008CN101292745A Pharmaceutical combination for preventing birth defect and improving anamnesis
10/29/2008CN101292744A Pharmaceutical combination for preventing birth defect and improving anamnesis
10/29/2008CN101292743A Pharmaceutical combination for preventing birth defect and improving anamnesis
10/29/2008CN101292689A Functional liver-protecting sobering up tea
10/29/2008CN101292687A Olive health-care tea and its preparing process
10/29/2008CN100429232C Vaughan Tristan J.
10/29/2008CN100429230C Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
10/29/2008CN100429229C Jingzhao toxin V
10/29/2008CN100429219C Celosia argentea suponin compound and its pharmaceutical use
10/29/2008CN100429214C Preparation of 1-aza-2-oxa-dibenzo [e,h] azulenes and their use for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
10/29/2008CN100429210C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
1 ... 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 ... 1833